Related references
Note: Only part of the references are listed.Effect of pristimerin on apoptosis through activation of ROS/ endoplasmic reticulum (ER) stress-mediated noxa in colorectal cancer
Qun Zhao et al.
PHYTOMEDICINE (2021)
Pristimerin synergistically sensitizes conditionally reprogrammed patient derived-primary hepatocellular carcinoma cells to sorafenib through endoplasmic reticulum stress and ROS generation by modulating Akt/FoxO1/p27kip1 signaling pathway
Yubo Tang et al.
PHYTOMEDICINE (2021)
Pristimerin suppresses colorectal cancer through inhibiting inflammatory responses and Wnt/β-catenin signaling
Qun Zhao et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2020)
Identification of a novel tumor angiogenesis inhibitor targeting Shh/Gli1 signaling pathway in Non-small cell lung cancer
Xueping Lei et al.
CELL DEATH & DISEASE (2020)
Pristimerin induces apoptosis and inhibits proliferation, migration in H1299 Lung Cancer Cells
Jiajun Li et al.
JOURNAL OF CANCER (2020)
Anti-Cancer Effects of Pristimerin and the Mechanisms: A Critical Review
Jia-jun Li et al.
FRONTIERS IN PHARMACOLOGY (2019)
Pristimerin attenuates cell proliferation of uveal melanoma cells by inhibiting insulin-like growth factor-1 receptor and its downstream pathways
Xinshu Xie et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Pristimerin induces apoptosis and autophagy via activation of ROS/ASK1/JNK pathway in human breast cancer in vitro and in vivo
Qun Zhao et al.
CELL DEATH DISCOVERY (2019)
Pristimerin targeting NF-B pathway inhibits proliferation, migration, and invasion in esophageal squamous cell carcinoma cells
Yuanqing Tu et al.
CELL BIOCHEMISTRY AND FUNCTION (2018)
Pristimerin, a naturally occurring triterpenoid, attenuates tumorigenesis in experimental colitis-associated colon cancer
Ju-Hyung Park et al.
PHYTOMEDICINE (2018)
Pristimerin effectively inhibits the malignant phenotypes of uveal melanoma cells by targeting NF-κB pathway
Biao Zhang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
A ntitumor effects of pristimerin on human osteosarcoma cells in vitro and in vivo
Yuki Mori et al.
ONCOTARGETS AND THERAPY (2017)
Pristimerin demonstrates anticancer potential in colorectal cancer cells by inducing G1 phase arrest and apoptosis and suppressing various pro-survival signaling proteins
Bashir A. Yousef et al.
ONCOLOGY REPORTS (2016)
Anti-cancer effect of pristimerin by inhibition of HIF-1α involves the SPHK-1 pathway in hypoxic prostate cancer cells
Seon-Ok Lee et al.
BMC CANCER (2016)
Pristimerin triggers AIF-dependent programmed necrosis in glioma cells via activation of JNK
Hongwei Zhao et al.
CANCER LETTERS (2016)
Endoplasmic Reticulum Stress Protein GRP78 Modulates Lipid Metabolism to Control Drug Sensitivity and Antitumor Immunity in Breast Cancer
Katherine L. Cook et al.
CANCER RESEARCH (2016)
The BCL-2 protein family, BH3-mimetics and cancer therapy
A. R. D. Delbridge et al.
CELL DEATH AND DIFFERENTIATION (2015)
Pristimerin inhibits angiogenesis in adjuvant-induced arthritic rats by suppressing VEGFR2 signaling pathways
Qiudi Deng et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
The roles of oxidative stress, endoplasmic reticulum stress, and autophagy in aldosterone/mineralocorticoid receptor-induced podocyte injury
Yanggang Yuan et al.
LABORATORY INVESTIGATION (2015)
Inhibitory action of pristimerin on hypoxia-mediated metastasis involves stem cell characteristics and EMT in PC-3 prostate cancer cells
Jianwei Zuo et al.
ONCOLOGY REPORTS (2015)
Prognostic Relevance of Circulating Tumor Cells in Blood and Disseminated Tumor Cells in Bone Marrow of Patients with Squamous Cell Carcinoma of the Oral Cavity
Alexander Groebe et al.
CLINICAL CANCER RESEARCH (2014)
Pristimerin, a quinonemethide triterpenoid, induces apoptosis in pancreatic cancer cells through the inhibition of pro-survival Akt/NF-κB/mTOR signaling proteins and anti-apoptotic Bcl-2
Dorrah Deeb et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Pristimerin induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation by blocking NF-κB signaling and depleting Bcr-Abl
Zhongzheng Lu et al.
MOLECULAR CANCER (2010)
Reactive Oxygen Species-Dependent Activation of Bax and Poly(ADP-ribose) Polymerase-1 Is Required for Mitochondrial Cell Death Induced by Triterpenoid Pristimerin in Human Cervical Cancer Cells
Joo-Yun Byun et al.
MOLECULAR PHARMACOLOGY (2009)
Pristimerin induces apoptosis by targeting the proteasome in prostate cancer cells
Huanjie Yang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae)
Anita M. Brinker et al.
PHYTOCHEMISTRY (2007)
Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1
F Urano et al.
SCIENCE (2000)
Share Paper
